Literature DB >> 17674324

Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein.

Charles A Specht1, Shuhua Nong, Jennifer M Dan, Chrono K Lee, Stuart M Levitz.   

Abstract

Mannoproteins are major antigens driving T cell responses to the opportunistic fungus Cryptococcus neoformans. To investigate the role played by mannosylation, an immunoreactive cryptococcal mannoprotein was expressed recombinantly in E. coli and Pichia pastoris, resulting in unglycosylated and mannosylated proteins, respectively. The Pichia-derived antigen stimulated stronger major histocompatibility class II-restricted T cell responses. Moreover, responses were potently inhibited if the antigen was chemically deglycosylated or if mannose receptors were blocked with mannans. Thus, mannosylation is critical for optimal T cell responses to a fungal antigen and should be taken into account when vaccines to protect against mycoses are designed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674324     DOI: 10.1086/520536

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

Review 2.  Fungal vaccines and immunotherapeutics.

Authors:  Evelyn Santos; Stuart M Levitz
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

3.  Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.

Authors:  Maureen M Hester; Chrono K Lee; Ambily Abraham; Payam Khoshkenar; Gary R Ostroff; Stuart M Levitz; Charles A Specht
Journal:  Vaccine       Date:  2019-11-04       Impact factor: 3.641

Review 4.  Exploiting fungal cell wall components in vaccines.

Authors:  Stuart M Levitz; Haibin Huang; Gary R Ostroff; Charles A Specht
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

5.  Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.

Authors:  Magdia De Jesus; André Moraes Nicola; Siu-Kei Chow; Ian R Lee; Shuhua Nong; Charles A Specht; Stuart M Levitz; Arturo Casadevall
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

Review 6.  Host immunity to Cryptococcus neoformans.

Authors:  Soma Rohatgi; Liise-Anne Pirofski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 7.  Vaccine immunity against fungal infections.

Authors:  Som G Nanjappa; Bruce S Klein
Journal:  Curr Opin Immunol       Date:  2014-03-03       Impact factor: 7.486

Review 8.  C-type lectin receptors orchestrate antifungal immunity.

Authors:  Sarah E Hardison; Gordon D Brown
Journal:  Nat Immunol       Date:  2012-08-21       Impact factor: 25.606

Review 9.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

Review 10.  A Call to Arms: Quest for a Cryptococcal Vaccine.

Authors:  Marley C Caballero Van Dyke; Floyd L Wormley
Journal:  Trends Microbiol       Date:  2017-11-02       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.